KOSIN UNIVERSITY COLLEGE OF MEDICINE
Search
- Page Path
- HOME > Search
Review article
- Gut microbiota and nonalcoholic fatty liver disease
- Boyeon Kim, Bukyung Kim
- Kosin Med J. 2023;38(3):169-175. Published online September 22, 2023
- DOI: https://doi.org/10.7180/kmj.23.138
- 8,041 View
- 91 Download
- 2 Citations
-
Abstract
PDF
PubReader 
ePub
- The gut microbiota has been reported to exert a significant influence on various physiological responses of hosts. Extensive evidence has recently emerged linking metabolic and cardiovascular disorders to the gut microbiota. Nonalcoholic fatty liver disease (NAFLD) is the most common underlying metabolic disorder, and its prevalence is increasing worldwide. In this study, we aim to review the relationship between the gut microbiota and NAFLD, and explore the potential of the gut microbiota as a novel target for NAFLD treatment.
-
Citations
Citations to this article as recorded by
- “Trust your gut”: exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studies
Wesam Bahitham, Yusra Banoun, Mutep Aljahdali, Ghufran Almuaiqly, Shahad M. Bahshwan, Linah Aljahdali, Faisal M. Sanai, Alexandre S. Rosado, Consolato M. Sergi
Frontiers in Nutrition.2025;[Epub] CrossRef - Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, Dorota Łojko, Sebastian Kraszewski, Ali Ibrahim, Maria Hussey, Adam Deptuła, Żaneta Grzywacz, Alexandre Ternianov, David Unwin
Journal of Clinical Medicine.2024; 13(16): 4857. CrossRef
- “Trust your gut”: exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studies
First
Prev
